Avalo Therapeutics, Inc.AVTXNASDAQ
Loading
Year-over-year operating cash flow growth rate
Percentile
P33
Within normal range
vs 2Y Ago
-1x
Contraction
Streak
2 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2024 | -59.90% |
| 2023 | -14.69% |
| 2022 | 62.27% |
| 2021 | -74.87% |
| 2020 | -111.87% |
| 2019 | -511.69% |
| 2018 | -124.99% |
| 2017 | 185.91% |
| 2016 | -43.39% |
| 2015 | 34.51% |